Literature DB >> 31427387

Peptide growth factors and their receptors in the vein wall.

Marta Bruczko-Goralewska1, Lech Romanowicz1, Justyna Bączyk1, Małgorzata Wolańska1, Krzysztof Sobolewski1, Radosław Kowalewski2.   

Abstract

The varicose vein wall remodeling is a very complex process, which is controlled by numerous factors, including peptide growth factors. The aim of the study was to assess a/b FGF, IGF-1, TGF-β1, VEGF-A and their receptors in the vein wall. Varicose vein samples were taken from 24 patients undergoing varicose vein surgery. The control material consisted of vein specimens collected from 12 patients with chronic limb ischemia. Contents of aFGF, bFGF, IGF-I, TGF-β1, VEGF, IGF-1R, VEGF R1 and VEGF R2 were assessed with ELISA method. Protein expression of FGF R1 and TGF-β RII were evaluated with western blot. Increased contents of aFGF, IGF-1 and VEGF-A were found in varicose veins in comparison with normal ones (p<0.05). In contrast, a significant decrease in TGF-β content was demonstrated in varicose veins (p<0.05). Furthermore, there was no difference in bFGF content in both groups (p>0.05). IGF-1 R content was significantly increased in varicose veins (p<0.05). There was no difference in VEGF R1 content between varicose and normal veins (p>0.05), whereas VEGF R2 content was significantly increased in varicose veins (p<0.05). Western blot demonstrated increased expression of TGF-β RII in varicose veins (p<0.05) and similar expression of FGF R1 in both groups (p>0.05). Demonstrated changes in peptide growth factors and their receptors may disturb metabolism of extracellular matrix in the varicose vein wall and contribute to the development of the disease to its more advanced stages. © American Federation for Medical Research 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  FGF; IGF-1; TGF-β1; VEGF; varicose veins

Mesh:

Substances:

Year:  2019        PMID: 31427387     DOI: 10.1136/jim-2019-001075

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  4 in total

1.  Chronic Venous Disease Patients Showed Altered Expression of IGF-1/PAPP-A/STC-2 Axis in the Vein Wall.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Ángel Asúnsolo; Clara Martínez-Vivero; Leonel Pekarek; Santiago Coca; Luis G Guijarro; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla; Felipe Sainz
Journal:  Biomed Res Int       Date:  2020-12-14       Impact factor: 3.411

2.  Chronic venous disease patients show increased IRS-4 expression in the great saphenous vein wall.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Cielo García-Montero; Fernando Ruiz-Grande; Silve Barrena; Hector Montoya; Leonel Pekarek; Sofia Zoullas; Miguel A Alvarez-Mon; Felipe Sainz; Angel Asúnsolo; Julio Acero; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla; Luis G Guijarro
Journal:  J Int Med Res       Date:  2021-09       Impact factor: 1.671

3.  Overexpression of glycolysis markers in placental tissue of pregnant women with chronic venous disease: a histological study.

Authors:  Miguel A Ortega; Miguel A Sáez; Oscar Fraile-Martínez; Miguel A Álvarez-Mon; Cielo García-Montero; Luis G Guijarro; Ángel Asúnsolo; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla; Juan A De León-Luis; Coral Bravo
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

4.  Abnormal proinflammatory and stressor environmental with increased the regulatory cellular IGF-1/PAPP-A/STC and Wnt-1/β-Catenin canonical pathway in placenta of women with Chronic venous Disease during Pregnancy.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Miguel A Saez; Miguel A Álvarez-Mon; Ana M Gómez-Lahoz; Coral Bravo; Juan A De León Luis; Felipe Sainz; Santiago Coca; Ángel Asúnsolo; Jorge Monserrat; Luis G Guijarro; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.